Skip to main content
International Journal of Molecular Sciences logoLink to International Journal of Molecular Sciences
. 2026 Oct 24;27(21):9493. doi: 10.3390/ijms27219493

Regulatory Elements and Splicing Factors Govern Mutually Exclusive Splicing of DmRdl Exon 3

Zijiao Song 1,†, Yichi Zhang 1,†, Kaixiang Lin 1, Xiugen Wang 1, Yanan Duan 1, Jian Bao 1, Chris Bass 2, Chunqing Zhao 1,*
Editor: Naoyuki Kataoka
PMCID: PMC13762713  PMID: 43027746

Abstract

Ionotropic γ-aminobutyric acid (GABA) receptors are major inhibitory receptors in insect central nervous systems, with their diversity partly generated by alternative splicing. In Drosophila melanogaster, mutually exclusive alternative splicing (MEAS) of the resistant to dieldrin gene (Rdl) exon 3 (E3) produces Rdl-3a and Rdl-3b, but its regulatory mechanism remains unclear. In the present study, two intronic regulatory elements (IREs) and one exonic regulatory element (ERE) were identified in the exon 2 (E2)–exon 4 (E4) region of DmRdl precursor mRNA (pre-mRNA). The IRE1 mutation decreased exon 3b (E3b) inclusion from 54.12% to 3.95%, whereas the IRE2 mutation increased E3b inclusion from 61.70% to 97.82%. The ERE mutation significantly increased E3b inclusion both in vitro and in vivo, while the IRE mutations were lethal in vivo. The results of RNA pull-down, mass spectrometry, and RNAi demonstrated that the splicing factors, CG30122 and Rbp1-like bind to the ERE and exert opposite effects on E3b inclusion. The results of STRING network analysis supported the functional interaction between CG30122 and Rbp1-like, while molecular docking provided structural support for their potential interaction with the ERE-containing RNA sequence. This study reveals the molecular regulatory network underlying the MEAS of DmRdl E3, and and provides a foundation for investigating other MEAS exons, such as E6 and E9 in insect Rdl.

Keywords: exon 3, DmRdl, mutually exclusive alternative splicing, CG30122, Rbp1-like

1. Introduction

Mutually exclusive alternative splicing (MEAS) is a form of alternative splicing in which only one exon from a cluster of tandemly arranged alternative exons is retained in the mature mRNA [1]. It enables a single gene to encode multiple protein isoforms, expanding the diversity of the transcriptome and proteome, and is critical for cell differentiation, organismal development, and the stress response [2,3,4]. MEAS is common in gene families such as ion channels, cell adhesion molecules, and transcription factors, and is essential for their functional specificity [5]. For example, the Drosophila melanogaster down syndrome cell adhesion molecule gene (Dscam) contains 95 variable exons, and MEAS of exons 4, 6, 9, and 17 can potentially generate 38,016 distinct mRNA isoforms with potential impacts on neural wiring and immune defense [6].

The resistant to dieldrin gene (Rdl) encodes a subunit of the ionotropic γ-aminobutyric acid (GABA) receptor, which is a major inhibitory neurotransmitter receptor in the insect central nervous system (CNS) [7]. The GABA receptor precisely regulates neuronal signaling and is essential for maintaining the normal excitation–inhibition balance in the insect CNS [8]. Rdl is also the primary target site for several major classes of neurotoxic insecticides including cyclodienes (dieldrin) and phenylpyrazoles (fipronil), and mutation of Rdl subunit in insects can lead to of insects against insecticides [9,10].

Exon 3 (E3) of the Rdl subunit undergoes conserved MEAS and may impact insect physiology [11,12]. The MEAS of Rdl E3 was first reported in D. melanogaster and resulted in changes in residues upstream of loop D, which is proposed to form a connection between the ligand-binding and transmembrane domains [13]. MEAS of Rdl generates two splice variants, Rdl-3a and Rdl-3b [12,13,14,15], which increases the structural diversity of insect GABA receptors, and potentially contributes to insect nervous system function, growth and development [8,13,14,16,17]. Therefore, understanding the regulatory mechanism underlying MEAS of DmRdl E3 may provide insight into the molecular basis of functional diversity within the insect CNS.

To date, the steric hindrance and competing RNA secondary structure models have been recognized as mechanisms specialized for regulating MEAS, whereas RNA–protein interactions represent a more general mechanism that regulates alternative splicing [18,19,20]. Under the RNA–protein interaction mechanism, precise regulation of MEAS depends on the coordinated interplay between regulatory elements, including exonic and intronic splicing enhancers and silencers [21], and splicing factors such as heterogeneous nuclear ribonucleoproteins (hnRNPs) [22] and serine/arginine-rich (SR) proteins [23,24]. In general, splicing factors bind to regulatory elements to enhance or inhibit spliceosome recognition of splice sites, thereby controlling the initiation and selection of MEAS events.

In the present study, we systematically investigated the mechanism underlying MEAS of DmRdl E3 due to the role of Rdl in insecticide resistance [15]. The potential contributions of steric hindrance and competing RNA secondary structure were first evaluated, followed by an investigation of the regulatory role of RNA–protein interactions. Thereafter, two intronic regulatory elements (IRE1 and IRE2) and one exonic regulatory element (ERE) were identified and were found to affect the inclusion of exon 3a (E3a)/exon 3b (E3b) in vivo. Subsequently, two splicing factors interacting with the ERE, CG30122 and Rbp1-like, were identified by RNA pull-down, mass spectrometry (MS) assays, and RNAi assays. Our findings elucidate the molecular mechanism governing the MEAS of DmRdl E3 and lay a foundation for further elucidating the regulatory networks of MEAS in DmRdl involved in insect neural development and physiological homeostasis.

2. Results

2.1. Subsection Identification of IREs in DmRdl Pre-mRNA

The predicted distance between the predicted branch site and the 5′ splice site of DmRdl E3b was 1755 nt, exceeding the 60 nt threshold. In addition, IE3 is a conserved intronic element predicted to be required for forming all three RNA secondary structures; however, its deletion did not affect E3b selection (Figure S9). These results suggest that neither steric hindrance nor competing RNA secondary structures are the primary mechanism underlying MEAS of DmRdl E3. We therefore investigated the interactions between splicing factors and regulatory elements.

First, the intron between E3a and E4 was divided into five segments (segments 1 to 5), and the corresponding deletion constructs (E3a-E4-Intdel1 to E3a-E4-Intdel5) were individually generated (Figure S1A). Among these constructs, only E3a-E4-Intdel5, corresponding to deletion of segment 5, affected the MEAS of DmRdl E3 (Figure S1B). Segment 5 was then further divided into five subsegments (segments 51 to 55) (Figure S2), and subsegment 55 was further divided into two smaller segments (segments 551 and 552) (Figure S3A) to identify the core nucletotide sequence. The results showed that the deletion of segment 552 disrupted the MEAS of DmRdl E3 (Figure S3B), suggesting that the key regulatory element resides within this segment.

Based on the sequence alignment of segment 552 from 16 Drosophila species, two conserved sequences, CS1 and CS2 (Figure S4A), were selected for further analysis to identify the core sequence for MEAS of DmRdl E3. CS2 was further subdivided and subjected to segment replacement (Figure S4B–E, Figure 1A,B), and a 6 nt sequence (Text S1) within CS2 was identified as the core sequence (Figure 1A), with replacement of IRE1 significantly decreasing E3b inclusion from 54.12% to 3.95% (Figure 1B).

Figure 1.

Figure 1

Identification of IREs mediating MEAS of DmRdl E3. Schematic of the replacement constructs E3a-E4-Intdel552-rep221 and E3a-E4-Intdel552-rep222 (A) and E3b-E3a-rep (C). Splicing patterns of the transfected E3a-E4-Intdel552-rep221 construct (B) and E3b-E3a-rep construct (D) in S2 cells, as detected by RT-PCR. The replaced region is indicated in red. The E3b inclusion level was calculated as the proportion of E3b relative to the total inclusion of E3b and E3a. Data are presented as mean ± standard error (SE) of three independent experiments. *** indicate p < 0.001.

Similarly, a regulatory element was identified in the intron between E3b and E3a of DmRdl. This intron was divided into seven segments (segment 1–7), and the corresponding deletion constructs (E3b-E3a-Intdel1 to E3b-E3a-Intdel7) were generated individually (Figure S5A). Deletion of segments 1 and 2 affected the MEAS of DmRdl E3 (Figure S5B). Based on the sequence alignment and the identification of overlapping regions among segments 1-3, a 6 nt sequence was identified and designated IRE2 as a potential regulatory element (Figure 1C), replacement of IRE2 significantly increased E3b inclusion from 61.70% to 97.82% (Figure 1D).

2.2. Identification of EREs in DmRdl Pre-mRNA

To identify EREs in E3, E3b and E3a were swapped (Figure 2A). As a result, E3b inclusion was almost abolished, decreasing from 57.57% to 3.56% (Figure 2B), suggesting that an ERE resides within E3b or E3a and contributes to the MEAS of DmRdl E3.

Figure 2.

Figure 2

Identification of an ERE mediating MEAS of DmRdl E3. Schematic of the WT, Exon-swap constructs (A) and the substitution constructs generated from E3b (C). Splicing patterns of the transfected WT and Exon-swap constructs (B) and substitution constructs (D) in S2 cells, as detected by RT-PCR. Detailed information for the mutant series is shown in Figure S6. The exon inclusion level was calculated by comparing E3b or E3a to the sum of E3b and E3a. Data are presented as mean ± standard error (SE) of three independent experiments. ns indicates no significant difference (p > 0.05), *** indicate p < 0.001.

Subsequently, E3b was divided into five consecutive segments, each of which was replaced individually with the corresponding sequence from E3a (Figure 2C). Among these constructs, replacement of E3b-Sub1 (Figure S6) significantly increased E3b inclusion from 63.02% to 81.00% (Figure 2D), and E3b-Sub1 region was therefore defined as an ERE.

2.3. In Vivo Validation of the Regulatory Elements in MEAS of DmRdl E3

To investigate the in vivo function of IRE1, IRE2, and ERE, we generated the RdlE3a-E4-rep, RdlE3b-E3a-rep, and RdlE3bms fly strains via CRISPR/Cas9. For the RdlE3bms fly strain, 800 G0 embryos were injected and 32 adults emerged. These 32 G0 adults were then individually crossed with nos.Cas9 flies. After G1 eclosion, individuals carrying the RdlE3bms allele were identified by sequencing. Among the 23 G0 crossed vials that produced G1 progeny, only one cross vial was positive for the RdlE3bms allele. The remaining 30 G1 male flies from this positive line were individually crossed to carrying the balancer chromosome to screen for positive heterozygous individuals (Figure 3A). Among the G1 parents that successfully produced G2 progeny, four carried the RdlE3bms allele. Positive G2 flies carrying the RdlE3bms allele in trans with the TM2 Ubx130/TM6B Tb1 balancer were intercrossed to obtain homozygous mutant G3 progeny. Homozygous mutant flies were then isolated from the G3 offspring, thereby establishing the homozygous RdlE3bms line (Figure 3B).

Figure 3.

Figure 3

Generation and validation of RdlE3bms by CRISPR/Cas9 genome editing. (A) Crossing procedure used to establish homozygous RdlE3bms flies. (B) Genomic DNA sequencing of heterozygous and homozygous RdlE3bms flies. (C) Inclusion levels of DmRdl E3b and E3a in w1118 and RdlE3bms flies. ** indicate p < 0.01.

The same procedures were used to establish the RdlE3a-E4-rep, RdlE3b-E3a-rep fly strains (Table S1, Figures S7 and S8). Unexpectedly, homozygous lethality was observed in both lines; therefore, RT-qPCR analysis was not performed for these mutants. The overall MEAS pattern in the homozygous RdlE3bms line was consistent with that observed in S2 cells, while E3b inclusion was significantly increased (Figure 3C).

2.4. RNA Pull-Down to Screen Splicing Factors Bound to the ERE

The RdlE3a-E4-rep and RdlE3b-E3a-rep strains were homozygous lethal, therefore, the subsequent analyses focused exclusively on the ERE. Both in vitro and in vivo experiments confirmed that the ERE plays a critical role in MEAS of DmRdl E3. To identify potential splicing factors involved in MEAS by binding to ERE, RNA pull-down assays were performed using ERE-WT and ERE-mut probes (Figure 4A). The results showed that the ERE-WT probe captured more of the cellular proteins than the ERE-mut probe (Figure 4B). Mass spectrometry analysis identified a total of 343 differentially enriched proteins (DEPs) that differed significantly between the ERE-WT and ERE-mut pull-down conditions (FDR ≤ 0.05 and |log2(FC| ≥ 1; Table S2).

Figure 4.

Figure 4

Identification of potential ERE-binding splicing factors involved in the MEAS of DmRdl E3. (A) Sequences of the ERE-WT and ERE-mut RNA probes. The ERE is highlighted in yellow, whereas sequence differences between the two probes are shown in red. (B) Proteins isolated by RNA pull-down were separated by 10% SDS-PAGE and visualized by silver staining. (C) GO and (D) KEGG enrichment analysis of DEP-associated genes identified by mass spectrometry after RNA pull down. Dot size represents the number of enriched genes, color intensity represents enrichment significance (−log10(p-value)), and the x-axis indicates the rich factor. (E) Venn diagram showing the overlap between genes enriched in key GO terms and KEGG pathways.

GO enrichment analysis showed that the DEP-associated genes were mainly enriched in GO terms related to intracellular anatomical structures and organelles, including intracellular anatomical structure, intracellular membrane-bounded organelle and organelle, as well as in four RNA- associated GO terms, such as RNA processing, nuclear protein-containing complex, mRNA metabolic process, and RNA binding (Figure 4C). To further narrow down the candidate splicing factors, intersection analysis of these four RNA-associated GO terms identified 141 overlapping genes for subsequent functional validation.

KEGG enrichment analysis showed that the DEP-associated genes were mostly enriched in pathways related to RNA metabolism and splicing (such as RNA degradation, spliceosome, and mRNA surveillance pathways), as well as in other pathways, such as the cGMP-PKG signaling pathway (Figure 4D). To further narrow down candidate splicing factors, 26 overlapping genes for subsequent functional validation were identified by intersection analysis of three RNA metabolism and splicing pathways.

In the Venn diagram analysis of genes enriched in key GO functional terms and KEGG pathways, 25 overlapping genes were identified between them (Figure 4E) and four potential ERE-binding splicing factors, CG30122, Hrb97D, Rb97D, and Rbp1-like, were selected for subsequent functional validation based on their annotation as members of the hnRNP or SR protein families, two canonical classes of splicing factors.

2.5. CG30122 and Rbp1-like Bind to ERE to Regulate the MEAS of DmRdl E3

To investigate the regulatory role of four potential ERE-binding splicing factors (CG30122, Hrb97D, Rb97D, and Rbp1-like) in vitro, functional splicing assays were performed in S2 cells using RNAi. The mRNA levels of four potential splicing factor genes were significantly reduced after RNAi treatment (p < 0.01; Figure 5A). However, E3b inclusion in DmRdl transcripts was significantly affected only by knockdown of CG30122 and Rbp1-like, and CG30122. E3b inclusion significantly decreased from 43.41% to 22.18% upon knockdown of CG30122, whereas it significantly increased E3b inclusion from 39.19% to 64.13% upon knockdown of Rbp1-like (Figure 5B), which indicated that CG30122 and Rbp1-like exert opposing effects on the MEAS of DmRdl E3.

Figure 5.

Figure 5

Identification and functional characterization of the splicing factors regulating DmRdl E3. (A) Relative mRNA expression levels of splicing factors following RNAi. The dsEGFP treatment served as a control. (B) Inclusion of DmRdl E3b 48h after RNAi. (C) PPI network generated using the STRING database. Molecular docking model showing the predicted binding of Rbp1-like protein (D) and CG30122 protein (E) to the DmRdl ERE. The yellow dashed lines represent hydrogen bond interactions. Error bars represent the mean ± standard error (SE) of three biological replicates. ns indicates no significant difference (p > 0.05). **, and *** indicate p < 0.01 and p < 0.001.

To examine the functional relationship between CG30122 and Rbp1-like, STRING network analysis was performed (Figure 5C). The resulting network showed that CG30122 was associated with Rbp1-like and yps, and Rbp1-like occupied a central position and was connected to multiple RNA-processing and splicing-related proteins, including CG30122, SmD3, Rb97D, Caper and qkr54B. These results suggest that CG30122 and Rbp1-like canparticipate in the MEAS of DmRdl E3 through distinct but interconnected regulatory networks.

The ERRAT scores of interaction models, Rbp1-like–ERE and CG30122–ERE, were 90.698 and 85.235, respectively. In addition, 78.10% and 69.40% of residues in the two interaction models were located in the most favored regions of the Ramachandran plot (Table S3). In the predicted binding modes with ERE (Figure 5D,E), there were five hydrogen bonds identified at the Rbp1-like–ERE interface (ARG44: U5; TYR41: C6; LYS12: C7; SER82: U8; ASN45: G9), whereas three hydrogen bonds were identified at the CG30122–ERE interface (VAL11: C3; ARG802: G12; THR793: A14).

3. Discussion

Ionotropic GABA receptors are the major inhibitory neurotransmitter receptors in the insect CNS and important targets of insecticides. The MEAS of DmRdl E3 increases the diversity of the GABA receptor and thereby plays a role in regulating their physiological function [11,15]. In the previous studies, steric hindrance and competing RNA secondary structures are able to regulate MEAS in several genes [19,25,26,27,28,29,30]; our results do not support either mechanism as a primary determinant of the DmRdl E3 MEAS (Figure S9). Furthermore, among the regulatory elements located between E2 and E4, the three key elements (IRE1, IRE2 and ERE) predictably cannot form stable pairwise RNA secondary structures, indicating that a competing RNA secondary structure mechanism is also unlikely to account for the MEAS of DmRdl E3. Therefore, we investigated the regulatory mechanism underlying DmRdl E3 by identifying the regulatory elements involved in E3 selection using RNA-protein interaction assays. Through sequential deletion, fragment replacement and substitution mutagenesis, the key regulatory elements (IRE1, IRE2 and ERE) were mapped to the core motifs ranging from 6–13 nt (Figure 6).

Figure 6.

Figure 6

Schematic of regulatory elements (IRE1, IRE2, ERE) governing the MEAS of DmRdl E3.

Mutation of the 6 nt IRE1, which is located 80 nt upstream of E4, caused a near-complete shift toward E3a inclusion, confirming its central role in the MEAS of DmRdl E3 (Figure 1A). Other studies have demonstrated that IREs still influence the recognition of distal splice sites through RNA-protein complexes, even if they are located far from alternative exons [25,26]. A typical example is the Fox-1 and Fox-2 proteins, which bind to the specific UGCAUG motif to regulate alternative splicing. This motif is highly enriched in the 400 nt downstream of nervous system-specific exons [27], and this long-range regulatory mode is consistent with the proposed function of the IRE1. Based on this long-range regulatory model, IRE1 may promote E3a inclusion by recruiting specific splicing factors.

The substantial increase in E3b inclusion following IRE2 mutation suggests that this element plays a key role in maintaining the balance of E3 selection. A similar positional arrangement has been reported for an IRE in FGFR2, which is likewise downstream of the 5′ splice site of exon IIIb [28]. Such positional similarity of IRE2 to the 5′ splice site suggests that IRE2 is likely at a key regulatory site for splicing regulation. Previous studies showed that IREs adjacent to splice sites often act by recruiting splicing repressors such as hnRNP A1 and PTB, thereby interfering with U1 snRNP recognition or by destabilizing the exon definition complex and ultimately repressing exon inclusion [29,30]. Because alternative exons generally possess weak splice sites, the location of IRE2 may allow it to occlude key recognition regions surrounding the 5′ splice site and inhibit its recognition. Upon mutation, the inhibitory effect is relieved, U1 snRNP binding is enhanced, and E3b becomes nearly constitutively included, resembling the regulatory mode of the IRE in SMN2 exon 7 [29].

Both RdlE3a-E4-rep and RdlE3b-E3a-rep fly strains were homozygous lethal. The lethality is highly unlikely to be driven by off-target effects, as heterozygous mutants were viable and fertile, and the intended replacements were verified by Sanger sequencing. Therefore, we speculated that the homozygous lethality probably is due to the essential role of IRE1 and IRE2 in maintaining the correct E3a/E3b balance. The IRE1 mutation nearly abolished E3b inclusion from 54.12% to 3.95%, whereas the IRE2 mutation increased it to near-constitutive inclusion (97.82%). Such extreme changes would drastically alter the ratio of E3a- and E3b-containing Rdl transcripts. Because different Rdl splice variants differ in GABA sensitivity [16], and E3 encoding residues contribute to the ligand-binding domain, this imbalance would impair receptor function and cause lethality. Consistent with this result, deletion of a GATA1-binding site in ALAS2 intron 1 disrupts a long-range enhancer loop and causes embryonic lethality in mice [31]. Thus, the homozygous lethality of these mutants provides strong evidence in vivo that the precise regulation of DmRdl E3 splicing is essential for viability.

In this study, the identified ERE was located at the 5′ end of E3b and adjacent to the 3′ splice acceptor site, and exhibited a consistent splicing regulatory effect in both S2 cells and D. melanogaster in vivo. Mutation of the ERE significantly promoted E3b inclusion in both systems. E3b is already the predominant isoform in wild-type D. melanogaster (93.75 ± 0.24%), whereas E3a is expressed at a very lower level (6.25 ± 0.24%). Because these isoforms are mutually exclusive, the modest absolute increase in E3b inclusion is accompanied by an equivalent absolute decrease in E3a, representing a substantial relative reduction in the low-abundance E3a isoform. Thus, the ERE likely fine-tunes the E3a/E3b balance in vivo rather than acting as a binary switch, in cooperation with the IREs and associated RNA-binding proteins. Given its position, the ERE may influence 3’ splice site recognition, exon definition, and early spliceosome assembly. Short sequence variations near exon boundaries can markedly alter exon inclusion levels [32,33,34]. For instance, a single-nucleotide difference in SMN2 exon 7 drastically shifts its splicing pattern toward exon 7 skipping, which constitutes a key molecular basis of spinal muscular atrophy [35]. This finding highlights that even extremely short exonic functional sequences can decisively affect alternative splicing. We speculated that, the position-mapping experiments, such as relocating the ERE within E3b, would further clarify the relative contributions of position and sequence to its regulatory activity.

Similarly, the subtle mutations near E10 of the tau markedly affect exon inclusion, further supporting the idea that sequences close to exon boundaries exert strong effects on exon selection [36]. Although EREs also reside in the central region of exons [35,37], those near the 3’ or 5’ splice sites are likely to exert stronger effects on exon inclusion. It is likely achieved through affecting splicing factors recruitment and local RNA–protein complex assembly. Although the ERE is only 13 nt in length, its location at the 5’ end of E3b likely confers strong splicing regulatory activity.

The RNA pull-down and RNAi results reveal that ERE can directly interact with CG30122 or Rbp1-like, which exert opposite effects on E3b inclusion. Specifically, E3b inclusion was significantly reduced by 21.23% upon knockdown of CG30122, whereas it was significantly increased by 24.94% upon knockdown of Rbp1-like. This suggests that the ERE is not merely a simple binding site mediating unidirectional control, but also a key regulatory element that integrates the opposite effects of two RNA-binding proteins. In wild-type D. melanogaster, E3b predominates over E3a. In S2 cells, the basal level of E3b inclusion is lower (43.41 ± 2.49%), but E3b inclusion was reduced by 21.23% upon knockdown of CG30122, whereas it was increased by 24.94% upon knockdown of Rbp1-like, substantially shifting the E3a/E3b balance. Rdl-3a and Rdl-3b are functionally different. For example, LsRdl-3a6b is more sensitive to fipronil than LsRdl-3c6b in Laodelphax striatellus, and DmRdl-3b6b has a higher GABA EC50 than DmRdl-3a6b in D. melanogaster. Thus, the modest changes in E3b may affect receptor function and insecticide sensitivity, with physiological and toxicological relevance. Similar regulatory principles have also been reported in other alternative splicing systems [38]. For example, in SMN2 exon 7, the exon inclusion is determined by the opposing activities of SRSF1 and hnRNP A1, which promotes and repress inclusion, respectively. Ultimately, the final splicing outcome depends on the relative occupancy and activities of SRSF1 and hnRNP A1on the regulatory region [35].

Although the RNAi-induced change in E3b inclusion was moderate (~20%), it was statistically significant, and the two factors exerted opposite effects, consistent with their opposing roles in E3 selection. In S2 cells, E3b inclusion was approximately 40–60% after transfection with the WT plasmid; therefore, an absolute change of ~20% represents a substantial shift in the E3a/E3b balance. Regarding potential off-target effects, the dsRNAs were designed to be gene-specific, and the two knockdowns produced opposite effects on E3b inclusion, which is difficult to explain by a common off-target mechanism. In addition, RNA pull-down independently confirmed that both CG30122 and Rbp1-like bind the ERE, providing direct biochemical evidence for their involvement. Although off-target effects cannot be entirely excluded, the functional and biochemical evidence together supports the specificity of the observed splicing changes.

Likewise, in the mutually exclusive selection of FGFR2 exons IIIb and IIIc, the same local pre-mRNA regulatory region can be modulated by Fox family proteins, hnRNP proteins, and other auxiliary factors, to generate distinct exon selection outcomes in different cell types [39]. Similarly, the classical splicing regulation of Drosophila doublesex also depends on the cooperative assembly of multiple RNA-binding proteins at EREs [40]. In our study, STRING interaction network analysis showed that Rbp1-like is linked to CG30122, as well as to spliceosome-related proteins such as SmD3 (Figure 5C), suggesting that these factors may participate in a dynamic protein complex that competitively or cooperatively associates with the ERE, thereby influencing early spliceosome assembly and exon recognition.

Molecular docking results suggested that Rbp1-like and CG30122 bind spatially adjacent but not fully overlapping sites on the ERE (Figure 5D,E) and Rbp1-like mainly occupied the middle region, whereas CG30122 preferentially bound for both ends. This spatial arrangement may affect local ERE conformation and the binding of other RNA-binding proteins. Thus, this ERE is a composite regulatory element that integrates the opposing effects of multiple RNA-binding proteins.

In summary, this study explored and excluded roles for the steric hindrance and competing RNA secondary structure models in the MEAS of DmRdl E3, systematically identified two IREs and one ERE in the DmRdl pre-mRNA, and verified the function of the ERE in vivo using the CRISPR/Cas9 system. Furthermore, RNA pull-down combined with RNAi confirmed that CG30122 and Rbp1-like bind to this ERE, and thereby regulate the MEAS of DmRdl E3. Collectively these findings provide new insights into the mechanisms underpinning transcriptomic diversity in an important neuronal receptor involved in diverse processes and a key target of insect pest control agents.

4. Materials and Methods

4.1. S2 Cell Culture and Drosophila Strains

Drosophila S2 cells were cultured at 27 °C in Schneider’s Drosophila Medium (Thermo Fisher Scientific Inc., Waltham, MA, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS, Thermo Fisher Scientific Inc.) and 1% penicillin–streptomycin (Thermo Fisher Scientific Inc.).

The Drosophila strains w1118, nos.Cas9 (stock #54591; Bloomington Drosophila Stock Center), and TM2 Ubx130/TM6B Tb1 (stock #FWB00002; Fungene Biotech, Qidong, China) were used as the wild-type (WT) strain, the zeroth generation (G0) strain for genome editing, and the balancer strain, respectively. All Drosophila strains were maintained on a standard fly diet at 25 °C under a relative humidity of 60–70%, and a photoperiod of 12:12 h (L/D) [41].

4.2. Prediction of Splice Branch Site, and RNA Secondary Structures

In tests of the steric hindrance model, the splice branch site for intron between E3b and E3a in the DmRdl pre-mRNA (Figure S10) was predicted using the LaBranchoR tool (https://github.com/jpaggi/LaBranchoR, accessed on 18 October 2024) with a 70 nt sequence upstream of the 3′ splice site as input, as described in a previous report [42]. If the distance between the 5’ splice site and the splice branch site exceeded 60 nt, the steric hindrance model was considered unlikely to account for MEAS.

In tests of the competing RNA secondary structure model, genomic Rdl sequences from 16 Drosophila species belonging to the family Drosophilidae were retrieved from the National Center for Biotechnology Information (NCBI) database (Table S4) and aligned using the MEGA-X software (v10.2.0) [43] to identify the conserved sequences, which were then used to predict RNA secondary structures with RNA Folding Form V2.3 (https://www.unafold.org/mfold/applications/rna-folding-form-v2.php, accessed on 30 October 2024) [44].

4.3. Plasmid Construction and Transfection of S2 Cells

A genomic fragment (Figure S10) of the DmRdl, including E2, exon 4 (E4), and the complete intronic and exonic (e.g., E3a and E3b) sequences between E2 and E4, including E3a and E3b, was amplified by PCR from the genomic DNA of w1118, and used as the wild-type (WT) minigene. Subsequently, the WT minigene was inserted into the pMT/V5-HisB vector (Thermo Fisher Scientific Inc.) via the KpnI and ApaI sites using the ClonExpress II One Step Cloning Kit (Vazyme Biotech Co., Ltd., Nanjing, China) to generate the WT construct.

To disrupt RNA secondary structures and precisely identify the regulatory element positions, we adopted a strategy combining stepwise segmental deletion and fragment replacement of conserved regions. Then, a series of deletion or replacement constructs (Text S1 and Table S5) were introduced into the WT construct using PCR-based site-directed mutagenesis with specific primers (Table S6). All constructs were verified by Sanger sequencing at General Biol Anhui Co., Ltd., Chuzhou, China.

To generate the Exon-swap construct, the E3b in the WT construct was exchanged with E3a using homologous arms and PCR (Table S6), followed by homologous recombination with the ClonExpress II One Step Cloning Kit. The same procedure was subsequently used to replace exon 3a with exon 3b. A series of substitution constructs (E3b-Sub1 to E3b-Sub5) were generated by swapping E3b with subregions of E3a using PCR-based site-directed mutagenesis (Table S6).

The WT, deletion, or substitution constructs (Table S5) were transfected into S2 cells using Lipofectamine 3000 Transfection Reagent (Thermo Fisher Scientific Inc.). After 5 h post-transfection, CuSO4 (100 mM) was added to activate the metallothionein promoter and thereby induce minigene expression. The cells were harvested 48 h after transfection.

4.4. Quantification of mRNA Splice Isoforms

Total RNA from S2 cells transfected with each construct was extracted using TRIzol Reagent (Thermo Fisher Scientific Inc.). First-strand cDNA was synthesized by reverse transcription using the PrimeScript II 1st Strand cDNA Synthesis Kit (Takara Bio. Inc., Kusatsu, Japan). The reaction system for RT-PCR contained 12.5 μL of 2× Phanta® Master Mix, 1 μL of cDNA template, 1 μL of DmRdl-det-F and -R primers (10 µM), and 9 μL of ddH2O. The PCR procedure was as follows: 95 °C for 3 min; 34 cycles of 95 °C for 15 s, 61 °C for 15 s, 72 °C for 30 s; followed by a final elongation at 72 °C for 5 min. PCR products were digested with exon-specific restriction enzymes (AluI was used for all constructs except the E3b-Sub4 construct, for which ClaI was used) and detected by 3% agarose gel electrophoresis (Figure S11). Images were captured using the Tanon-6600 Gel Imaging System, and the mRNA isoforms were quantified by analyzing the gray values of the DNA bands using ImageJ software (v1.52a;Bethesda, MD, USA) [45]. Data were expressed as percentages of mean and SE, and the error bars were calculated from three biological replicates. The significance of differences was determined by the two-tailed Student’s t-test, and p < 0.05 was deemed to indicate statistical significance.

4.5. CRISPR Design and Plasmid Construction

Potential CRISPR target sequences within the genomic region were identified using the online platform CRISPR Optimal Target Finder (http://tools.flycrispr.molbio.wisc.edu/targetFinder/, accessed on 8 May 2025). Two sgRNA target sequences without predicted off-target sites (Table S7) were selected and cloned into the pCFD4 vector backbone (Addgene#49411) [46] using specific primers (Table S7) to generate the sgRNA plasmid.

Three ~2.5 kb PCR products containing IRE1, IRE2 or ERE and their respective ~1.2 kb upstream and downstream sequences, were amplified from the genomic DNA of the nos. Cas9 strain as the template using specific primers (Table S7). The resulting fragments were ligated into the pEASY-Blunt3 vector (TransGen Biotech, Beijing, China) to generate pEASY-Blunt3-IRE1, pEASY-Blunt3-IRE2, and pEASY-Blunt3-ERE, respectively.

In pEASY-Blunt3-IRE1, pEASY-Blunt3-IRE2, and pEASY-Blunt3-ERE, IRE1, IRE2, and ERE were replaced with the corresponding replacement fragments E3a-E4-Intdel552-rep221, E3b-E3a-rep and E3b-Sub1, respectively. In addition, synonymous mutations were introduced into the protospacer adjacent motif (PAM) sequences to improve the efficiency of editing [47] using the Fast Mutagenesis System (TransGen Biotech) with specific primers (Table S7), thereby generating the donor plasmid for embryo microinjection. The resulting genome-edited fly strains were designated RdlE3a-E4-rep, RdlE3b-E3a-rep, and RdlE3bms, corresponding to replacement of IRE1, replacement of IRE2, and multiple substitutions in E3b within the ERE region, respectively.

4.6. Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR)

For gene expression analysis, total RNA was extracted from S2 cells subjected to RNAi treatment with dsCG30122, dsHrb97D, dsRb97D and dsRbp1-like, as well as from the RdlE3bms and w1118 strain, respectively and reverse-transcribed into cDNA. RT-qPCR was performed in a 20 μL reaction mixture containing 2 μL of cDNA template, 10 μL of 2× ChamQ Universal SYBR qPCR Master Mix (Vazyme Biotech Co., Ltd.), 0.4 μL each of forward and reverse primers (10 μM; Table S8), designed with Beacon Designer 7 (Premier Biosoft International, Palo Alto, CA, USA), and 7.2 μL of nuclease-free water. Amplification was performed on an ABI 7500 system under the following conditions: 95 °C for 30 s, 40 cycles of 95 °C for 5 s and 60 °C for 34 s, followed by a melting curve program of 95 °C for 15 s, 60 °C for 60 s and 95 °C for 1 s. Three technical replicates were performed for each biological sample. The relative expression levels of E3b and E3a were normalized to Actin as the internal reference gene.

Data from RT-qPCR assays were exported from the ABI 7500 SDS 1.4 software (Thermo Fisher Scientific Inc.). The comparative cycle threshold (Ct) values were analyzed using Sequence Detection Software 1.4 (Thermo Fisher Scientific Inc.) and Excel 2016 (Microsoft). For fly samples, RT-qPCR was performed using isoform-specific primers for E3b and E3a (Table S8), with Actin as the internal reference. E3b inclusion was calculated by qPCR as described previously [48]. The relative abundance of E3 isoform (E3b or E3a) was calculated as 2−ΔCT, where ΔCt = Ctisoform − CtActin. E3b inclusion was then calculated as the relative abundance of E3b divided by the sum of the relative abundances of E3a and E3b, multiplied by 100%. For comparisons between fly strains, the calculated E3b inclusion percentages were used directly. For RNAi experiments, relative mRNA expression levels of target genes were calculated using the 2−ΔΔCT method [49]. Statistical comparisons were performed using one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparisons in IBM SPSS Statistic 22.0 software (SPSS Inc.). Figures were prepared using GraphPad Prism 6.0 (GraphPad Software Inc.).

4.7. RNA Pull-Down and LC-MS/MS

Two 3′-biotin-labeled RNA probes, the wild-type ERE probe (ERE-WT) and the mutant ERE probe (ERE-mut), in which the ERE sequence was replaced with the corresponding sequence present in the E3b-Sub1 substitution construct, were synthesized (GenScript Inc., Piscataway, NJ, USA) to capture RNA-protein complexes from whole-cell extracts of S2 cells transfected with the WT construct for 48 h.

Whole-cell extracts from S2 cells were prepared as previously described [50]. Three independent biological replicates were performed for each probe. The biotin-labeled RNA probe (1 μg) was incubated with 50 μL of Mag-SA streptavidin magnetic beads (Bioeast Inc., Ltd., Hangzhou, China) at 4 °C for 1 h. Subsequently, 400 μg of whole-cell extracts were added and incubated at 4 °C for an additional 1 h. After incubation, the beads were collected by magnetic separation and washed three times with ice-cold PBS, with the supernatant removed after each wash. Finally, 40 μL of 2× SDS loading buffer was added, and the samples were boiled for 10 min. The resulting RNA-binding proteins were separated by SDS-PAGE and visualized by silver staining to identify differential bands between ERE-WT probe and ERE-mut probe pull-down samples.

In addition, the resulting RNA-bound proteins were separated by SDS-PAGE and stained with Coomassie brilliant blue. The stained bands were then excised, cut into small pieces, and destained with 50% acetonitrile (ACN) in 50 mM ammonium bicarbonate. The gel pieces were subsequently reduced with 10 mM DTT for 30 min, alkylated with 10 mM iodoacetamide (Sigma, St. Louis, MO, USA) at room temperature for 20 min, and digested with trypsin (Promega Corporation, Madison, WI, USA). The resulting peptides were extracted from the gel, collected, desalted, dried, and redissolved for LC-MS/MS analysis.

4.8. Bioinformatic Analysis of DEPs

The resulting peptides were analyzed by LC-MS/MS, and the resulting protein abundance data were further analyzed using Perseus software (v2.1.6.0) [51]. After data normalization and filtering of low-abundance proteins, differential proteins between the ERE WT and ERE mut probe groups were identified using two-tailed Student’s t-test. The raw p-values were corrected using the Benjamini and Hochberg method to control the false discovery rate (FDR), and proteins with FDR ≤ 0.05 and |log2(fold change, FC)| ≥ 1 were defined as DEPs.

Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed using the OmicShare tools (http://www.omicshare.com/tools, accessed on 21 November 2025). The genes corresponding to the DEPs identified by RNA pull-down coupled with LC-MS/MS were mapped to GO terms in the GO database (http://www.geneontology.org/, accessed on 21 November 2025) and to KEGG pathway terms in the KEGG database (https://www.genome.jp/kegg/, accessed on 21 November 2025). Enrichment of GO terms and KEGG pathways was assessed against the D. melanogaster background gene set using hypergeometric tests. The resulting p-values were adjusted via false discovery rate (FDR) correction, with FDR ≤ 0.05 as the significance threshold.

To construct the protein–protein interaction (PPI) network, all identified DEPs were submitted to STRING version 11.5 (https://string-db.org/, accessed on 30 December 2025). The subset of DEPs predicted to interact with the two identified splicing factors was extracted and used to construct the PPI network with a medium confidence score threshold of 0.400. The resulting network was visualized and exported directly from the STRING platform.

Molecular docking between the splicing factor (Text S2) and ERE sequence of DmRdl pre-mRNA (Text S1) was performed using AlphaFold 3.0 (https://www.alphafoldserver.com, accessed on 19 February 2026). An inter-protein Template Modeling score (ipTM) > 0.6 was considered indicative of a meaningful interaction. The predicted complexes were further analyzed structurally and visualized using PyMOL (v1.8) [52].

4.9. RNA Interference (RNAi) Assay

Double-stranded RNA (dsRNA) targeting splicing factor (CG30122, Hrb97D, Rb97D, or Rbp1-like) was synthesized using the T7 RNAi Transcription Kit (Vazyme Biotech Co., Ltd.) from DNA templates flanked by T7 promoter sequences and amplified with specific primers (Table S8). S2 cells were seeded into 6-well plates and cultured to 60–80% confluence. For co-transfection, 2 μg of WT plasmid and 2 μg dsRNA were added to each well, with dsEGFP as the negative control. Subsequently, the expression levels of DmRdl E3 splice variants after RNAi was analyzed by RT-qPCR with Actin as internal references.

Total RNA was extracted after 48 h post-transfection and specific primers (Table S8) for RT-qPCR were designed based on the E3 sequence of DmRdl. RNA purification, cDNA synthesis, RT-qPCR data analysis, statistical analysis was performed as described above. Amplification efficiency was evaluated, and product specificity was confirmed by melting curve analysis. Three biological replicates were analyzed, each with three technical replicates.

5. Conclusions

This study systematically identified two IREs and one ERE in the DmRdl pre-mRNA and verified the function of the ERE in vivo using the CRISPR/Cas9 system. Furthermore, RNA pull-down combined with RNAi confirmed that CG30122 and Rbp1-like bind to this ERE and thereby regulate the MEAS of DmRdl E3. Collectively, these findings provide new insights into the mechanisms underpinning transcriptomic diversity in an important neuronal receptor involved in diverse processes and a key target of insect pest control agents.

Acknowledgments

We give special thanks to Ali Hasnain (Nanjing Agricultural University) for helping in the language editing. Chunqing Zhao is thankful for the support from the China Scholarship Council. For the purpose of open access, the author has applied a ‘Creative Commons Attribution (CC BY)’ licence to any Author Accepted Manuscript version arising from this submission.

Abbreviations

The following abbreviations are used in this manuscript:

cDNA complementary DNA
CNS central nervous system
DEPs differentially enriched proteins
dsEGFP double-stranded RNA of enhanced green fluorescent protein
dsRNA double-stranded RNA
E2 exon 2
E3 exon 3
E3b exon 3b
E3a exon 3a
E4 exon 4
FC fold change
GABA γ-aminobutyric acid
MEAS mutually exclusive alternative splicing
pre-mRNA precursor mRNA
qRT-PCR quantitative reverse-transcription polymerase chain reaction
Rdl resistance to dieldrin gene
Rdl resistance to dieldrin protein
RNAi RNA interference
SE standard error
sgRNA single-guide RNA

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms27219493/s1.

Author Contributions

Conceptualization, C.Z.; validation, Z.S., Y.Z., K.L., Y.D.; formal analysis, Z.S., K.L.; investigation, Z.S., Y.Z., K.L., X.W., Y.D., J.B.; data curation, Z.S., Y.Z., K.L., X.W.; writing—original draft preparation, Z.S.; writing—review and editing, Z.S., Y.Z., K.L., X.W., Y.D., J.B., C.B., C.Z.; visualization, Z.S., K.L., X.W.; supervision, C.Z.; project administration, C.Z.; funding acquisition, Z.S., C.Z. All authors have read and agreed to the published version of the manuscript.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors on request, as the data are part of an ongoing study.

Conflicts of Interest

The authors declare no conflicts of interest.

Funding Statement

This research was funded by the National Key R&D Program of China, grant number 2022YFD1700200, and the Postgraduate Research Practice Innovation Program of Jiangsu Province, grant number KYCX23_0816. The APC was funded by Nanjing Agricultural University.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

References

  • 1.Smith C.W.J. Alternative splicing—When two’s a crowd. Cell. 2005;123:1–3. doi: 10.1016/j.cell.2005.09.010. [DOI] [PubMed] [Google Scholar]
  • 2.Nilsen T.W., Graveley B.R. Expansion of the eukaryotic proteome by alternative splicing. Nature. 2010;463:457–463. doi: 10.1038/nature08909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Pan Q., Shai O., Lee L.J., Frey B.J., Blencowe B.J. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 2008;40:1413–1415. doi: 10.1038/ng.259. Erratum in Nat. Genet. 2009, 41, 762. [DOI] [PubMed] [Google Scholar]
  • 4.Wang E.T., Sandberg R., Luo S.J., Khrebtukova I., Zhang L., Mayr C., Kingsmore S.F., Schroth G.P., Burge C.B. Alternative isoform regulation in human tissue transcriptomes. Nature. 2008;456:470–476. doi: 10.1038/nature07509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Baralle F.E., Giudice J. Alternative splicing as a regulator of development and tissue identity. Nat. Rev. Mol. Cell Biol. 2017;18:437–451. doi: 10.1038/nrm.2017.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zipursky S.L., Wojtowicz W.M., Hattori D. Got diversity? Wiring the fly brain with Dscam. Trends Biochem. Sci. 2006;31:581–588. doi: 10.1016/j.tibs.2006.08.003. [DOI] [PubMed] [Google Scholar]
  • 7.Taylor-Wells J., Hawkins J., Colombo C., Bermudez I., Jones A.K. Cloning and functional expression of intracellular loop variants of the honey bee (Apis mellifera) RDL GABA receptor. Neurotoxicology. 2017;60:207–213. doi: 10.1016/j.neuro.2016.06.007. [DOI] [PubMed] [Google Scholar]
  • 8.Buckingham S.D., Biggin P.C., Sattelle B.M., Brown L.A., Sattelle D.B. Insect GABA receptors: Splicing, editing, and targeting by antiparasitics and insecticides. Mol. Pharmacol. 2005;68:942–951. doi: 10.1124/mol.105.015313. [DOI] [PubMed] [Google Scholar]
  • 9.Zhou T., Wu W., Ma S., Chen J., Huang J., Qiao X. Effects of RDL GABA Receptor point mutants on susceptibility to meta-diamide and isoxazoline insecticides in Drosophila melanogaster. Insects. 2024;15:334. doi: 10.3390/insects15050334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Remnant E.J., Morton C.J., Daborn P.J., Lumb C., Yang Y.T., Ng H.L., Parker M.W., Batterham P. The role of Rdl in resistance to phenylpyrazoles in Drosophila melanogaster. Insect Biochem. Mol. Biol. 2014;54:11–21. doi: 10.1016/j.ibmb.2014.08.008. [DOI] [PubMed] [Google Scholar]
  • 11.del Villar S.G., Jones A.K. Cloning and functional characterisation of the duplicated RDL subunits from the pea aphid, Acyrthosiphon pisum. Int. J. Mol. Sci. 2018;19:2235. doi: 10.3390/ijms19082235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Wei Q., Wu S.F., Niu C.D., Yu H.Y., Dong Y.X., Gao C.F. Knockdown of the ionotropic γ-aminobutyric acid receptor (GABAR) RDL gene decreases fipronil susceptibility of the small brown planthopper, Laodelphax striatellus (Hemiptera: Delphacidae) Arch. Insect Biochem. Physiol. 2015;88:249–261. doi: 10.1002/arch.21232. [DOI] [PubMed] [Google Scholar]
  • 13.Yu L.L., Cui Y.J., Lang G.J., Zhang M.Y., Zhang C.X. The ionotropic γ-aminobutyric acid receptor gene family of the silkworm, Bombyx mori. Genome. 2010;53:688–697. doi: 10.1139/g10-056. [DOI] [PubMed] [Google Scholar]
  • 14.Ffrench-Constant R.H., Rocheleau T.A. Drosophila γ-aminobutyric acid receptor gene Rdl shows extensive alternative splicing. J. Neurochem. 1993;60:2323–2326. doi: 10.1111/j.1471-4159.1993.tb03523.x. [DOI] [PubMed] [Google Scholar]
  • 15.Liu G.Y., Ozoe F., Furuta K., Ozoe Y. 4,5-substituted 3-isoxazolols with insecticidal activity act as competitive antagonists of housefly GABA receptors. J. Agric. Food. Chem. 2015;63:6304–6312. doi: 10.1021/acs.jafc.5b01843. [DOI] [PubMed] [Google Scholar]
  • 16.Jones A.K., Buckingham S.D., Papadaki M., Yokota M., Sattelle B.M., Matsuda K., Sattelle D.B. Splice-variant- and stage-specific RNA editing of the Drosophila GABA receptor modulates agonist potency. J. Neurosci. 2009;29:4287–4292. doi: 10.1523/jneurosci.5251-08.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kita T., Mino H., Ozoe F., Ozoe Y. Spatiotemporally different expression of alternatively spliced GABA receptor subunit transcripts in the housefly Musca domestica. Arch. Insect Biochem. Physiol. 2019;101:e21541. doi: 10.1002/arch.21541. [DOI] [PubMed] [Google Scholar]
  • 18.Jin Y.F., Dong H.Y., Shi Y., Bian L.N. Mutually exclusive alternative splicing of pre-mRNAs. Wiley Interdiscip. Rev.-RNA. 2018;9:e1468. doi: 10.1002/wrna.1468. [DOI] [PubMed] [Google Scholar]
  • 19.Yue Y., Li G.L., Yang Y., Zhang W.J., Pan H.W., Chen R., Shi F., Jin Y.F. Regulation of Dscam exon 17 alternative splicing by steric hindrance in combination with RNA secondary structures. RNA Biol. 2013;10:1822–1833. doi: 10.4161/rna.27176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Lee Y., Rio D.C. Mechanisms and regulation of alternative pre-mRNA splicing. Annu. Rev. Biochem. 2015;84:291. doi: 10.1146/annurev-biochem-060614-034316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Buendia P., Tyree J., Loredo R., Hsu S.N. Identification of conserved splicing motifs in mutually exclusive exons of 15 insect species. BMC Genom. 2012;13:S1. doi: 10.1186/1471-2164-13-S2-S1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Chen M., Zhang J., Manley J.L. Turning on a fuel switch of cancer—hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA. Cancer Res. 2010;70:8977–8980. doi: 10.1158/0008-5472.can-10-2513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Jin X.L. Regulatory network of serine/arginine-rich (SR) proteins: The molecular mechanism and physiological function in plants. Int. J. Mol. Sci. 2022;23:10147. doi: 10.3390/ijms231710147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Long J.C., Caceres J.F. The SR protein family of splicing factors: Master regulators of gene expression. Biochem. J. 2009;417:15–27. doi: 10.1042/bj20081501. [DOI] [PubMed] [Google Scholar]
  • 25.Baralle M., Skoko N., Knezevich A., De Conti L., Motti D., Bhuvanagiri M., Baralle D., Buratti E., Baralle F.E. NF1 mRNA biogenesis: Effect of the genomic milieu in splicing regulation of the NF1 exon 37 region. FEBS Lett. 2006;580:4449–4456. doi: 10.1016/j.febslet.2006.07.018. [DOI] [PubMed] [Google Scholar]
  • 26.Buratti E., Baralle M., Baralle F.E. Defective splicing, disease and therapy: Searching for master checkpoints in exon definition. Nucleic Acids Res. 2006;34:3494–3510. doi: 10.1093/nar/gkl498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Venables J.P. Downstream intronic splicing enhancers. FEBS Lett. 2007;581:4127–4131. doi: 10.1016/j.febslet.2007.08.012. [DOI] [PubMed] [Google Scholar]
  • 28.Wagner E.J., Baraniak A.P., Sessions O.M., Mauger D., Moskowitz E., Garcia-Blanco M.A. Characterization of the intronic splicing silencers flanking FGFR2 exon IIIb. J. Biol. Chem. 2005;280:14017–14027. doi: 10.1074/jbc.m414492200. [DOI] [PubMed] [Google Scholar]
  • 29.Kashima T., Rao N., Manley J.L. An intronic element contributes to splicing repression in spinal muscular atrophy. Proc. Natl. Acad. Sci. USA. 2007;104:3426–3431. doi: 10.1073/pnas.0700343104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Sharma S., Kohlstaedt L.A., Damianov A., Rio D.C., Black D.L. Polypyrimidine tract binding protein controls the transition from exon definition to an intron defined spliceosome. Nat. Struct. Mol. Biol. 2008;15:183–191. doi: 10.1038/nsmb.1375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Zhang Y.C., Zhang J.L., An W.B., Wan Y., Ma S.H., Yin J., Li X.C., Gao J., Yuan W.P., Guo Y., et al. Intron 1 GATA site enhances ALAS2 expression indispensably during erythroid differentiation. Nucleic Acids Res. 2017;45:657–671. doi: 10.1093/nar/gkw901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Pagani F., Buratti E., Stuani C., Bendix R., Dörk T., Baralle F.E. A new type of mutation causes a splicing defect in ATM. Nat. Genet. 2002;30:426–429. doi: 10.1038/ng858. [DOI] [PubMed] [Google Scholar]
  • 33.Cartegni L., Chew S.L., Krainer A.R. Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat. Rev. Genet. 2002;3:285–298. doi: 10.1038/nrg775. [DOI] [PubMed] [Google Scholar]
  • 34.Jaganathan K., Panagiotopoulou S.K., McRae J.F., Darbandi S.F., Knowles D., Li Y.I., Kosmicki J.A., Arbelaez J., Cui W.W., Schwartz G.B., et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176:535–548. doi: 10.1016/j.cell.2018.12.015. [DOI] [PubMed] [Google Scholar]
  • 35.Cartegni L., Krainer A.R. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat. Genet. 2002;30:377–384. doi: 10.1038/ng854. [DOI] [PubMed] [Google Scholar]
  • 36.D’Souza I., Poorkaj P., Hong M., Nochlin D., Lee V.M.Y., Bird T.D., Schellenberg G.D. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc. Natl. Acad. Sci. USA. 1999;96:5598–5603. doi: 10.1073/pnas.96.10.5598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Blencowe B.J. Exonic splicing enhancers: Mechanism of action, diversity and role in human genetic diseases. Trends Biochem. Sci. 2000;25:106–110. doi: 10.1016/s0968-0004(00)01549-8. Erratum in Trends Biochem. Sci. 2000, 25, 228. [DOI] [PubMed] [Google Scholar]
  • 38.Erkelenz S., Mueller W.F., Evans M.S., Busch A., Schöneweis K., Hertel K.J., Schaal H. Position-dependent splicing activation and repression by SR and hnRNP proteins rely on common mechanisms. RNA. 2013;19:96–102. doi: 10.1261/rna.037044.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Mauger D.M., Lin C., Garcia-Blanco M.A. HnRNP H and hnRNP F complex with Fox2 to silence fibroblast growth factor receptor 2 Exon IIIc. Mol. Cell. Biol. 2008;28:5403–5419. doi: 10.1128/mcb.00739-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Lynch K.W., Maniatis T. Assembly of specific SR protein complexes on distinct regulatory elements of the Drosophila doublesex splicing enhancer. Genes Dev. 1996;10:2089–2101. doi: 10.1101/gad.10.16.2089. [DOI] [PubMed] [Google Scholar]
  • 41.Douris V., Steinbach D., Panteleri R., Livadaras I., Pickett J.A., Van Leeuwen T., Nauen R., Vontas J. Resistance mutation conserved between insects and mites unravels the benzoylurea insecticide mode of action on chitin biosynthesis. Proc. Natl. Acad. Sci. USA. 2016;113:14692–14697. doi: 10.1073/pnas.1618258113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Paggi J.M., Bejerano G. A sequence-based, deep learning model accurately predicts RNA splicing branchpoints. RNA. 2018;24:1647–1658. doi: 10.1261/rna.066290.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Kumar S., Stecher G., Li M., Knyaz C., Tamura K. MEGA X: Molecular evolutionary genetics analysis across computing platforms. Mol. Biol. Evol. 2018;35:1547–1549. doi: 10.1093/molbev/msy096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003;31:3406–3415. doi: 10.1093/nar/gkg595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Schneider C.A., Rasband W.S., Eliceiri K.W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods. 2012;9:671–675. doi: 10.1038/nmeth.2089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Zhang Y.C., Huang Q.T., Sheng C.W., Liu G.Y., Zhang K.X., Jia Z.Q., Tang T., Mao X., Jones A.K., Han Z.J., et al. G3’MTMD3 in the insect GABA receptor subunit, RDL, confers resistance to broflanilide and fluralaner. PLoS Genet. 2023;19:e1010814. doi: 10.1371/journal.pgen.1010814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Paquet D., Kwart D., Chen A., Sproul A., Jacob S., Teo S., Olsen K.M., Gregg A., Noggle S., Tessier-Lavigne M. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature. 2016;533:125–129. doi: 10.1038/nature17664. [DOI] [PubMed] [Google Scholar]
  • 48.Harvey S.E., Cheng C. Methods for characterization of alternative RNA splicing. Methods Mol. Biol. 2016;1402:229–241. doi: 10.1007/978-1-4939-3378-5_18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
  • 50.Kleiman F.E., Manley J.L. The BARD1-CstF-50 Interaction Links mRNA 3′ End Formation to DNA Damage and Tumor Suppression. Cell. 2001;104:743–753. doi: 10.1016/s0092-8674(01)00270-7. [DOI] [PubMed] [Google Scholar]
  • 51.Tyanova S., Temu T., Sinitcyn P., Carlson A., Hein M.Y., Geiger T., Mann M., Cox J. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods. 2016;13:731–740. doi: 10.1038/nmeth.3901. [DOI] [PubMed] [Google Scholar]
  • 52.Schrodinger L. The PyMOL Molecular Graphics System. Schrodinger, LLC; New York, NY, USA: 2015. Version 1.8. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors on request, as the data are part of an ongoing study.


Articles from International Journal of Molecular Sciences are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES